This in-body GPS system could track tumor movement in real-time

Researchers from Massachusetts Institute of Technology’s Computer Science and Artificial Laboratory have developed a wireless system that acts like an in-body GPS, allowing doctors to use sensors to track tumors or dispense drugs. The system, known as the ReMix, is able to pinpoint the location of ingestible implants inside the body by using low-power wireless

Smithwise helps startup find its focus

After Basil Leaf Technologies won the Qualcomm Tricorder XPrize in 2017, founder Dr. Basil Harris needed help figuring out how to bring this almost-all-in-one diagnostic tool to market. Basil Leaf’s mobile platform DxtER includes a group of non-invasive sensors that can wirelessly communicate with a smart device as they collect data on vital signs, body

This implantable mesh can monitor heart activity and apply stimulations

Researchers from the Center for Nanoparticle Research at the Institute for Basic Science have developed a wearable and implantable device that measures electrophysiological signals and stimulates as needed for pain relief, rehabilitation and prosthetic motor control. The soft implantable recorded cardiac activity in multiple points of a swine heart in tests. The researchers on the

BARDA, J&J launch ‘reimagined’ emergency respiratory device challenge

The Dept. of Health and Human Services’ Biomedical Advanced Research and Development Authority and Johnson & Johnson‘s (NYSE:JNJ) Janssen R&D are launching a new crowdsourced tech development challenge looking to support innovative respiratory protection devices, according to a recently listed government posting. The new contest, dubbed the QuickFire Challenge, will look to award up to

How sensors could help doctors determine effective cancer treatment options

Chemical engineers from Massachusetts Institute of Technology have developed a sensor that could help doctors determine what the best cancer treatment option is based on how cells react to different types of chemotherapy drugs. The sensors are designed to detect hydrogen peroxide in human cells, which could help researchers determine new cancer drugs that increase

NuVasive, Siemens ink spinal surgery joint dev deal

NuVasive (NSDQ:NUVA) said yesterday it inked a strategic partnership deal with Siemens (NYSE:SI) Healthineers looking to develop and advance technology designed for minimally invasive spinal surgery. Through the deal, dubbed the Spine Precision Partnership, the companies will look to jointly advance their proprietary technologies, looking to improve operating room workflow efficiency and the delivery of minimally disruptive spinal technologies,

How blood tests could diagnose brain injury

Researchers at the University of Rochester are studying a blood test that will help doctors determine if patients could have a traumatic brain injury following a blow to the head. Currently, physicians rely on subjective markers like headaches, nausea and light sensitivity to determine if there is bleeding or bruising in the brain. They made

Medpace prices $248m secondary offering

Medpace (NSDQ:MEDP) today priced an upcoming secondary offering which could bring in up to approximately $247.5 million. In the offering, the Cincinnati-based company said that investment funds affiliated with Cinven Capital Management will offer approximately 4.5 million shares of its stock at a price of $55 per share. Read the whole story on our sister site,

This tiny sensor could non-invasively monitor brain aneurysm treatment

Researchers have developed a stretchable sensor that can be used with a flow diverter in brain aneurysm treatments to track hemodynamics in blood vessels without diagnostic procedures. A collaborative team of researchers from Georgia Tech’s Institute for Electronics and Nanotechnology, the University of Pittsburgh and the Korea Institute of Materials Science have developed a sensor

Northwell’s prosthetic leg could get amputees back in the swim

A New York State heathcare provider has developed a 3D-printed artificial leg to help combat veterans and other amputees to swim again. Northwell Health’s  prosthetic, “The Fin,” is the first such prosthetic leg attachment to give amputee swimmers the ability to navigate from land to the water and back without having to switch prosthetics.  Northwell has begun

Researchers use microparticles for targeted delivery of brain cancer therapy

A team of researchers from Brigham & Women’s Hospital, Mass. Institute of Technology and Mass. General Hospital demonstrated that localizing the delivery of NAMPT inhibitors can extend survival in a mouse model of glioma, according to a paper published this week in the Proceedings of the National Academy of Sciences. The scientists created a test to check for a mutation linked

This non-invasive procedure could be an alternative to laser eye surgery

Engineers at Columbia University have developed a non-invasive approach that uses an ultrafast laser to correct vision problems like nearsightedness. The method uses a femtosecond oscillator that delivers pulses of very low energy at a high repetition rate. This allows for selective and localized alteration of biochemical and biomechanics properties of corneal tissues while changing

This medical air mist could eliminate hospital-acquired infections

Researchers at the University of California in San Diego have developed a medical misting device that can diffuse potent disinfectants into the air. The device has worked with a number of disinfectants that have not been atomized before, like Triethylene glycol. The researchers used the device to atomize disinfectants onto environmental surfaces that were contaminated

VisCardia heart failure implant study underway in Ukraine

Novel heart failure device developer VisCardia, Inc. (Portland, Ore.) announced the first implant of the VisONE system for heart failure and the launch of the system’s heart failure pilot study in Ukraine. The VisONE implantable system delivers asymptomatic diaphragmatic stimulation (ADS) therapy to improve cardiac function. A surgeon laparoscopically implants a medical device equipped with electrodes to deliver

GE Healthcare, Lantheus launch 2nd Phase 3 trial of PET imaging agent

GE Healthcare (NYSE: GE) and Lantheus Holdings, Inc. (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. have started a second Phase 3 clinical trial of flurpiridaz 18F, an investigational agent being evaluated for the detection of coronary artery disease. Flurpiridaz18F is designed as a positron emission tomography (PET) myocardial perfusion imaging (MPI) agent. The companies agreed in